NPI: 1386821932 · ROCKY HILL, CT 06067 · Professional Counselor · NPI assigned 01/25/2008
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 01/25/2008 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,198 | $84K |
| 2019 | 1,924 | $88K |
| 2020 | 29,151 | $298K |
| 2021 | 146,472 | $2.73M |
| 2022 | 70,733 | $1.13M |
| 2023 | 57,225 | $282K |
| 2024 | 43,022 | $165K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 68,866 | 59,428 | $1.78M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 154,853 | 127,851 | $1.76M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 10,604 | 9,744 | $425K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9,221 | 7,738 | $275K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8,088 | 7,242 | $190K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,969 | 2,723 | $166K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,711 | 1,522 | $84K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,237 | 1,028 | $23K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,256 | 3,995 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 182 | 175 | $11K |
| 90674 | 801 | 755 | $8K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,250 | 4,227 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 534 | 254 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 86 | 85 | $4K |
| 99201 | 127 | 121 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 288 | 273 | $3K |
| 0064A | 109 | 102 | $2K | |
| 90686 | 336 | 327 | $2K | |
| 0004A | 48 | 42 | $920.00 | |
| 86580 | 107 | 103 | $539.27 | |
| 3078F | 9,076 | 7,954 | $0.00 | |
| 1159F | 19,042 | 16,387 | $0.00 | |
| 1160F | 14,817 | 13,674 | $0.00 | |
| 3008F | 10,264 | 9,169 | $0.00 | |
| 3074F | 12,903 | 11,187 | $0.00 | |
| 1036F | 14,456 | 12,516 | $0.00 | |
| 3079F | 479 | 377 | $0.00 | |
| 0001A | 15 | 15 | $0.00 |